It is well established that stimulant medication improves classroom manageability and attention in terms of time on task, but does stimulant medication improve learning or long-term academic achievement in children with ADHD? There is no clear evidence that it does, but there are at least two reasons why beneficial effects may be obscured in research studies and clinical practice: (1) Higher-than-optimal doses may be prescribed if behavioral response (rather than cognitive response) is used to titrate the dose, and (2) treatment may be overinclusive if diagnostic groups are targeted in which a significant proportion of cases do not have favorable cognitive responses to medication. This article addresses these two issues and describes a large clinical series of patients who were evaluated using a double-blind medication assessment protocol designed to overcome some of the theoretical deficiencies suggested by these issues.
Get full access to this article
View all access options for this article.
References
1.
American Psychiatric Association (1968). Diagnostic and statistical manual of mental disorders (2nd ed.). Washington, DC: Author.
2.
American Psychiatric Association (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
3.
American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
4.
Barkley, R.A. (1977). A review of stimulant drug research with hyperactive children. Journal of Child Psychology and Psychiatry, 18, 137–165.
5.
Barkley, R.A., & Cunningham, C.E. (1978). Do stimulant drugs improve the academic performance of hyperkinetic children?Clinical Pediatrics, 8, 137–146.
6.
Barkley, R.A., Fischer, M., Newby, R.F., & Breen, M.J. (1988). Development of a multimethod clinical protocol for assessing stimulant drug response in children with attention deficit disorder. Journal of Clinical Child Psychology, 17, 14–24.
Bloomingdale, L.M. (Ed.). (1988). Attention deficit disorder (Vol. 3): New research in attention, treatment, and psychopharmacology. New York: Pergamon Press.
10.
Bloomingdale, L.M., & Sergeant, J. (Eds.). (1988). Attention deficit disorder (Vol. 5): Criteria, cognition, and intervention. New York: Pergamon Press.
11.
Bloomingdale, L.M., & Swanson, J.M. (Eds.). (1989). Attention deficit disorder (Vol. 4): Current concepts and emerging trends in attentional and behavioral disorders of childhood. New York: Pergamon Press.
12.
Bradley, C. (1937). The behavior of children receiving benzedrine. American Journal of Psychiatry, 94, 577–585.
13.
Bradley, C. (1950). Benzedrine and dexedrine in the treatment of children's behavior disorders. Pediatrics, 5, 24–37.
14.
Burns, J.T., House, R.F., Fensch, F.C., & Miller, J.G. (1967). Effects of magnesium pemoline and dextroamphetamine on human learning. Science, 152, 849–851.
15.
Cantwell, D.P. (1986). Attention deficit and associated disorders. In T. Millon & G.L Klerman (Eds.) Contemporary directions in psychopathology (pp. 402–428). New York: Guilford Press.
16.
Cantwell, D.P., & Carlson, G. (1978). Stimulants. In J. Werry (Ed.), Pediatric psychopharmacology and the use of behavior modifying drugs in children (pp. 171–207). New York: Brunner/Mazel.
17.
Conners, C.K. (1972). Stimulant drugs and cortical evoked responses in learning and behavior disorders in children. In W.L. Smith (Ed.), Drugs, development and cerebral function (pp. 179–199). Springfield, IL: Thomas.
18.
Connors, C.K. (1973). Rating scales for use in drug studies with children. Psychopharmacology Bulletin (Special Issue), 24–84.
19.
Conners, C.K., Eisenberg, L., & Sharpe, L. (1964). Effects of methylphenidate (Ritalin) on paired-associate learning and porteus maze performance in emotionally disturbed children. Journal of Consulting Psychology, 28, 14–22.
20.
Comblatt, B.A., Rische, N.J., Faris, G., Friedman, D., & Erlenmeyer-Kimling, L. (1988). The continuous performance test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Research, 26, 223–238.
21.
Cronbach, L.J., & Furby, L. (1970). How we should measure “change”—Or should we?Psychological Bulletin, 74, 68–80.
22.
Douglas, V.I. (1972). Stop, look and listen: The problem of sustained attention and impulse control in hyperactive children. Canadian Journal of Behavioral Science, 4, 259–282.
23.
Douglas, V.I., Barr, R.G., O'Neill, M.E., & Britton, B.G. (1986). Short term effects of methylphenidate on the cognitive, learning and academic performance of children with attention deficit disorder in the laboratory and the classroom. Journal of Child Psychology and Psychiatry, 27, 191–211.
24.
Douglas, V.I., Barr, R.G., O'Neill, M.E., & Britton, B.G. (1988). Dosage effects and individual responsivity to methylphenidate in attention deficit disorder. Journal of Child Psychology and Psychiatry, 29, 453–475.
25.
Douglas, V.I., & Peters, K.G. (1979). Toward a clearer definition of the attentional deficit of hyperactive children. In G. Hale & M. Lewis (Eds.) Attention and the development of cognitive style (pp. 173–247). New York: Pergamon Press.
26.
Elia, J., Borcherdling, B.G., Rapoport, J.L., & Keysor, G.S. (1990). Stimulant drug treatment of hyperactivity: Are there non-responders? Unpublished manuscript.
27.
Gadow, K.D. (1983). Effects of stimulant drugs on academic performance in hyperactive and learning disabled children. Journal of Learning Disabilities, 16, 290–299.
28.
Gadow, K. (1989). Dose-response effects of stimulant drugs: A clarification of issues. In L.M. Bloomingdale. & J.M. Swanson (Eds.) Attention deficit disorder IV: Emerging trends in attentional and behavioral disorders of childhood (pp. 25–66). New York: Pergamon Press.
29.
Gittelman, R. (1988). The assessment of hyperactivity: The DSM III approach. In L.M. Bloomingdale. & J.M. Swanson (Eds.) Attention deficit disorder V: Criteria, cognition and intervention (pp. 9–28). New York: Pergamon Press.
30.
Halliday, R., Callaway, E., & Rosenthal, J.H. (1984). The visual ERP predicts clinical response to methylphenidate in hyperactive children. Psychophysiology, 21, 114–121.
31.
ICD9 (1978). Mental disorders: Glossary and guide to their classification in accordance with the ninth revision of the international classification of diseases. Geneva: World Health Organization.
32.
Kinsbourne, M. (1977). The mechanism of hyperactivity. In M. Blau, I. Rapin, & M. Kinsbourne (Eds.) Topics in child neurology (pp. 289–306). New York: Spectrum Press.
33.
Kinsbourne, M., & Swanson, J.M. (1979). Models of hyperactivity: Implications for diagnosis and treatment. In R.L. Trites (Ed.), Hyperactivity in children: Etiology, measurement and treatment implications (pp. 1–20). Baltimore: University Park Press.
34.
Kinsbourne, M., & Swanson, J.M. (1980). Evaluation of symptomatic treatment of hyperactive behavior by stimulant drugs. In R.M. Knights. & D.J. Bakker (Eds.) Treatment of hyperactive and learning disordered children: Current research (pp. 207–217). Baltimore: University Park Press.
35.
Klorman, R., Salzman, L.F., & Borgstedt, A.D. (1988). Brain event-related potentials in evaluation of cognitive deficits in ADD and outcome of stimulant therapy. In L.M. Bloomingdale (Ed.), Attention deficit disorder III: New research in attention, treatment, & psychopharmacology (pp. 49–80). Oxford, England: Pergamon Press.
36.
Kupietz, S.S., Ellis, R., Gadow, K.D., & Winsberg, B.G. (1980). Effects of methylphenidate on learning a “beginning reading vocabulary” by normal adults. Psychopharmacology, 69, 69–72.
37.
Laufer, M.W., & Denhoff, E. (1957). Hyperactive behavior symptoms in children. Journal of Pediatrics, 50, 463–474.
38.
Linn, R.L., & Slinde, J.A. (1977). The determination of the significance of change between pre-and posttesting periods. Review of Educational Research, 47, 121–150.
39.
Loney, J., & Milich, R. (1982). Hyperactivity, inattention and aggression in clinical practice. Advances in Developmental and Behavioral Pediatrics, 3, 113–147.
Nuechterlein, K.H. (1983). Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and among hyperactive children. Journal of Abnormal Psychology, 92, 4–83.
42.
Peeke, S., Halliday, R., Callaway, E., Prael, R., & Reus, V. (1984). Effects of two doses of methylphenidate on verbal information processing in hyperactive children. Journal of Clinical Psychopharmacology, 4, 82–88.
43.
Pelham, W.E. (1983). The effects of psychostimulants on academic achievement in hyperactive and learning-disabled children. Thalamus, 3, 1–47.
44.
Pelham, W.E. (1989). Behavior therapy, behavioral assessment and psychostimulant medication in the treatment of attention deficit disorders: An interactive approach. In L.M. Bloomingdale. & J.M. Swanson (Eds.) Attention deficit disorder IV: Emerging trends in attentional and behavioral disorders of childhood (pp. 169–202). New York: Pergamon Press.
45.
Pelham, W.E., Bender, M.E., Caddell, J.M., Booth, S., & Moorer, S. (1985). The dose-response effects of methylphenidate on classroom academic and social behavior in children with attention deficit disorder. Archives of General Psychiatry, 42, 948–952.
46.
Pelham, W.E., & Murphy, H.A. (1986). Behavioral and pharmacological treatment of attention deficit and conduct disorders. In N. Herson (Ed.), Pharmacological and behavioral treatment: An integrative approach. New York: Wiley.
47.
Pelham, W.E., Schnedler, R.W., Bender, M.E., Nilsson, D.E., Miller, J., Budrow, M.S., & Ronnei, M. (1988). The combination of behavior therapy and methylphenidate in the treatment of attention deficit disorders: A therapy outcome study. In L.M. Bloomingdale (Ed.), Attention deficit disorder III: New research in attention, treatment and psychopharmacology (pp. 29–48). New York: Pergamon Press.
48.
Prendergast, M., Taylor, E.A., Rapoport, J.L., Bartko, J., Donnelly, M., Zametkin, A., Ahearn, M.B., Dunn, G., & Wieselberg, H.M. (1988). The diagnosis of childhood hyperactivity: A US-UK cross-national study of DSM-III and ICD-9. Journal of Child Psychology and Psychiatry, 29, 289–300.
49.
Quinn, P.O., & Rapoport, J.L. (1975). One-year follow-up of hyperactive boys treated with imipramine or methylphenidate. American Journal of Psychiatry, 132, 241–245.
50.
Rapoport, J.L., Buchsbaum, A., Zahn, T.P., Weingartner, H., Ludlow, C., & Mikkelsen, E.J. (1978). Dextroamphetamine: Cognitive and behavioral effects on normal prepubertal boys. Science, 199, 560–563.
51.
Rapoport, J.L., & Zametkin, A. (1988). Drug treatment of attention deficit disorder. In L.M. Bloomingdale. & J.M. Swanson (Eds.) Attention deficit disorder V: Criteria, cognition and intervention (pp. 161–182). New York: Pergamon Press.
52.
Rapport, M.D., Stoner, G., DuPaul, G.J., Birmingham, B.K., & Tucker, S. (1985). Methylphenidate in hyperactive children: Differential effects of dose on academic, learning and social behavior. Journal of Abnormal Child Psychology, 13, 227–244.
53.
Riddle, K.D., & Rapoport, J.L. (1976). Two-year follow-up of 72 hyperactive boys. Journal of Nervous and Mental Diseases, 162, 126–134.
54.
Safer, D.J., & Krager, J.M. (1984). Trends in medication therapy for hyperactivity—National and international perspectives. In K.D. Gadow (Ed.), Advances in learning and behavioral disabilities (pp. 125–150). Greenwich, CT: JAI Press.
55.
Satterfield, J.H., Cantwell, D.P., & Satterfield, B.T. (1979). Multimodality treatment: A one-year follow-up of 84 hyperactive boys. Archives of General Psychiatry, 36, 965–974.
56.
Satterfield, J.H., Satterfield, B.T., & Cantwell, D.P. (1980). Multimodality treatment: A two-year evaluation of 61 hyperactive boys. Archives of General Psychiatry, 37, 915–919.
57.
Satterfield, J.H., Satterfield, B.T., & Cantwell, D.P. (1981). Three-year multimodality treatment study of 100 hyperactive boys. Journal of Pediatrics, 98, 650–655.
58.
Satterfield, J.H., Satterfield, B.T., & Schell, A.M. (1987). Therapeutic interventions to prevent delinquency in hyperactive boys. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 56–64.
59.
Sergeant, J. (1989). In search of processing deficits in attention in ADD-H children. In L.M. Bloomingdale. & J.M. Swanson (Eds.) Attention deficit disorder IV: Emerging trends in attentional and behavioral disorders of childhood (pp. 255–282). New York: Pergamon Press.
60.
Shaywitz, B., & Shaywitz, S. (1988). Attention deficit disorder: Current perspectives. In J.F. Kavanagh. & T.J. Truss (Eds.) Learning disabilities: Proceedings of the national conference (pp. 369–523). Parkton, MD: York Press.
61.
Smith, R.G. (1967) Magnesium pemoline: Lack of facilitation in human learning, memory, and performance tests. Science, 152, 603–605.
62.
Sprague, R.L., & Gadow, K.D. (1976). The role of the teacher in drug treatment. School Review, 85, 109–140.
63.
Sprague, R.L., & Sleator, E.K. (1976). Drugs and dosages: Implications for learning disabilities. In R.M. Knights. & D.J. Bakker (Eds.) The neuropsychology of learning disorders (pp. 351–366). Baltimore: University Park Press.
64.
Sprague, R.L., & Sleator, E.K. (1977). Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science, 198, 1274–1276.
65.
Swanson, J.M. (1985). Measures of cognitive functioning appropriate for use in pediatric psychopharmacological research studies. Psychopharmacological Bulletin, 21, 887–890.
66.
Swanson, J.M. (1988a). Measurement of serum concentrations and behavioral response in ADDH children to acute doses of methylphenidate. In L.M. Bloomingdale (Ed.), Attention deficit disorder III: New research in attention, treatment and psychopharmacology (pp. 107–126). New York: Pergamon Press.
67.
Swanson, J.M. (1988b). What do psychopharmacological studies tell us about information processing deficits in attention deficit disorder? In L.M. Bloomingdale. & J. Sergeant (Eds.) Attention deficit disorder IV: Criteria, cognition and intervention (pp. 97–115). New York: Pergamon Press.
68.
Swanson, J.M. (1988c). Discussion: Attention deficit disorder. In J.F. Kavanagh. & T.J. Truss (Eds.) Learning disabilities: Proceedings of the national conference (pp. 532–546). Parkton, MD: York Press.
69.
Swanson, J.M. (1989). Paired associate learning in the assessment of ADD-H children. In L.M. Bloomingdale. & J.M. Swanson (Eds.) Attention deficit disorder V: Emerging trends in attentional and behavioral disorders of childhood (pp. 87–124). New York: Pergamon Press.
70.
Swanson, J.M., Barlow, A., & Kinsbourne, M. (1979). Task specificity of responses to stimulant drugs in laboratory tests. International Journal of Mental Health, 8, 67–82.
71.
Swanson, J.M., & Cantwell, D. (1989, November). Dose-related effects of methylphenidate on stimulus encoding and memory comparison times in ADHD children. Paper presented at the meeting of the American Academy of Child and Adolescent Psychiatry, New York.
72.
Swanson, J.M., & Kinsbourne, M. (1976). Stimulant-related state-dependent learning in hyperactive children. Science, 92, 1754–1756.
73.
Swanson, J.M., & Kinsbourne, M. (1978). Should you use stimulants to treat the hyperactive child?Modern Medicine, 46, 71–80.
74.
Swanson, J.M., & Kinsbourne, M. (1979). The cognitive effects of stimulant drugs on hyperactive children. In M. Hale & T. Lewis (Eds.) Attention and cognitive development (pp. 249–274). New York: Plenum Press.
75.
Swanson, J.M., Kinsbourne, M., Roberts, W., & Zucker, K. (1978). A time response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics, 61, 21–29.
76.
Swanson, J.M., Neuchterlein, K., Asarnow, R., & Hunt, R. (1989). Use of a common software system for collaborative clinical research in schizophrenia and ADHD. Behavior Research Methods, Investments and Computers, 21, 250–254.
77.
Swanson, J.M., Sandman, C.A., Deutsch, C., & Baren, M. (1983). Methylphenidate (Ritalin) given with or before breakfast: I. Behavioral, cognitive and electrophysiological effects. Pediatrics, 72, 49–55.
78.
Tannock, R., Schachar, R.J., Carr, R.P., & Logan, G.D. (1989). Dose-response effects of methylphenidate on academic performance and overt behavior in hyperactive children. Pediatrics, 84, 648–657.
79.
Taylor, E.A. (1988). Diagnosis of hyperactivity—A British perspective. In L.M. Bloomingdale. & J. Sergeant (Eds.) Attention deficit disorder V: Criteria, cognition and intervention (pp. 141–159). New York: Pergamon Press.
80.
Taylor, E.A., Schachar, R., Thorley, G., Wieselberg, H.M., Everitt, B., & Rutter, M. (1987). Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behavior. Psychological Medicine, 17, 121–143.
81.
Ullmann, R.K., & Sleator, E.K. (1986). Responders, nonresponders and placebo responders among children with attention deficit disorder. Clinical Pediatrics, 25, 594–599.
82.
Varley, C.K., & Turpin, E.W. (1982). Double-blind assessment of stimulant medication for attention deficit disorder: A model for clinical application. American Journal of Orthopsychiatry, 52, 542–547.
83.
Weiss, G., & Hechtman, L.T. (1986). Hyperactive children grown up. New York: Guilford Press.
84.
Weiss, G., Kruger, E., Danielson, U., & Elman, M. (1975). Effect of long-term treatment of hyperactive children with methylphenidate. Canadian Medical Association Journal, 112, 159–165.
85.
Werry, J.S. (1989). Differential diagnosis of attention deficits and conduct disorder. In L.M. Bloomingdale. & J.M. Swanson (Eds.) Attention deficit disorder V: Criteria, cognition and intervention (pp. 83–96). New York: Pergamon Press.
86.
Whalen, C.K., & Henker, B. (1976). Psychostimulants and children: A review and analysis. Psychological Bulletin, 83, 1113–1130.
87.
Whalen, C.K., & Henker, B. (1984). Hyperactivity and the attention deficit disorders: Expanding frontiers. Pediatric Clinics of North America, 31, 397–427.
88.
Zametkin, A. (1989). The psychopharmacological investigation of attention deficit disorder. In L.M. Bloomingdale. & J.M. Swanson (Eds.) Attention deficit disorder IV: Emerging trends in attentional and behavioral disorders of childhood (pp. 151–168). New York: Pergamon Press.
